Targeted therapy against VEGFR and EGFR signaling with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic mouse model of human non-small cell lung cancer

被引：0
|
作者：
Shibuya, K
Komaki, R
Wu, W
Shintani, T
Itasaka, S
Isobe, T
Ryan, A
Herbst, RS
O'Reilly, MS
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] AstraZeneca, Macclesfield, Cheshire, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
35
引用
收藏
页码：S149 / S150
页数：2
相关论文
共 50 条
  • [21] EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
    Antonicelli, Alberto
    Cafarotti, Stefano
    Indini, Alice
    Galli, Alessio
    Russo, Andrea
    Cesario, Alfredo
    Lococo, Filippo Maria
    Russo, Patrizia
    Mainini, Alberto Franco
    Bonifati, Luca Giuseppe
    Nosotti, Mario
    Santambrogio, Luigi
    Margaritora, Stefano
    Granone, Pierluigi Maria
    Dutly, Andre Emanuel
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (03): : 320 - 330
  • [22] Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts
    Chen, Shan
    Liu, Xiaoxia
    Gong, Wenfei
    Yang, Huan
    Luo, Daofei
    Zuo, Xialin
    Li, Wenshi
    Wu, Ping
    Liu, Li
    Xu, Qian
    Ji, Aimin
    ONCOLOGY REPORTS, 2013, 29 (01) : 260 - 268
  • [23] TUSC2 immunogene therapy enhances efficacy of immunotherapy and targeted drugs in human non-small cell lung cancer (NSCLC) in humanized mouse models
    Meraz, Ismail M.
    Majidi, Mourad
    Feng, Meng
    Shao, RuPing
    Ha, Min Jin
    Shpall, Elizabeth J.
    Roth, Jack A.
    CANCER RESEARCH, 2020, 80 (16)
  • [24] EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities
    La Monica, Silvia
    CELLS, 2022, 11 (08)
  • [25] EGFR-TARGETED SELECTIVE GENE THERAPY FOR NON-SMALL CELL LUNG CANCER (NSCLC)
    Yamaguchi, Miki
    Nakamura, Kiminori
    Sakuragi, Naoya
    Kato, Kazunori
    Hamada, Hirofumi
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1056 - 1057
  • [26] Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer
    Chhouri, Houssein
    Alexandre, David
    Grumolato, Luca
    CANCERS, 2023, 15 (02)
  • [27] The Role and Therapeutic Potential of Non-coding RNAs in Resistance to EGFR - TKIs Targeted Therapy for Non-small Cell Lung Cancer
    Zhang, Yang
    Chen, Ye
    Lu, Lili
    Xie, Xiu-Li
    Huan, Ren
    Wu, Li-Fang
    Tan, Li-Na
    Xu, Tao
    Jin, Yong
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [28] Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells
    Saygideger-Kont, Yasemin
    Minas, Tsion Zewdu
    Jones, Hayden
    Hour, Sarah
    Celik, Haydar
    Temel, Idil
    Han, Jenny
    Atabey, Nese
    Erkizan, Hayriye Verda
    Toretsky, Jeffrey A.
    Uren, Aykut
    NEOPLASIA, 2016, 18 (02): : 111 - 120
  • [29] ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer model
    Matsurnori, Yuka
    Yano, Seiji
    Goto, Hisatsugu
    Nakataki, Emiko
    Wedge, Stephen R.
    Ryan, Anderson J.
    Sone, Saburo
    ONCOLOGY RESEARCH, 2006, 16 (01) : 15 - 26
  • [30] Efficacy of targeted therapy in patients with non-small cell lung cancer harboring very rare mutations in EGFR exon 18
    Zhang, Yuanyuan
    Zeng, Hao
    Qi, Chang
    Tan, Sihan
    Huang, Qin
    Pu, Xin
    Suda, Kenichi
    Santarpia, Mariacarmela
    Tian, Panwen
    Li, Yalun
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 875 - 884
12345